JM Financial has set a target price of ₹1,093 on Fortis Healthcare stock, a potential upside of 22.7 per cent from Friday's closing price
Stocks to Watch today, Dec 22: Varun Beverages, KEC International, PVR Inox, Rites, Tech M, and Crompton Greaves are some of the other stocks to watch today
Healthcare chain to invest Rs 840 crore to expand the facility's capacity to 300 beds, eyes over 1500 beds in the city by 2028
Analysts say IHH's play may include improving revenue per bed by lifting clinical mix
The Morgan Stanley Capital International (MSCI) Global Standard Index to include Fortis Healthcare, GE Vernova, Paytm, Siemens Energy from Dec 1, 2205; here's a trading strategy in these 4 stocks.
Fortis Healthcare and GE Vernova have rallied 41 per cent and 51 per cent, respectively, compared to an 8.2 per cent advance in the Nifty50
Ambit analysts see HDFC Bank benefiting from accelerating credit growth, normalisation in cost of funds, and focus on high-yield segments like MSME, gold, and unsecured retail loans.
Domestic brokerage firm Nuvama analysts forecast a modest sequential slowdown but a healthy ~17 per cent year-on-year (Y-o-Y) Ebitda growth, led by hospitals and diagnostics.
Hospital shares were in demand on Monday amid reports that the health ministry revised rates for nearly 2,000 medical procedures under the Central Government Health Services (CGHS) scheme.
In 2018, price was set at ₹170/share; Fortis Healthcare now trades at ₹980.10
Shares of Fortis Healthcare and Yatharth Hospital hit new life-time highs at ₹892.70 and ₹719 in trades on Thursday.
Fortis Healthcare Q1FY26 profit rises 53% to ₹266.78 crore as hospital and diagnostics businesses drive 16.6% revenue growth and Ebitda margin improves to 22.6%
Q1 FY26 company results, August 6: Bayer CropScience, Cera Sanitaryware, EID Parry India, Godrej Agrovet, and Pidilite are also to release their April-June quarter earnings reports today
Bosch, Radico Khaitan, Maharashtra Scooters and Schneider Electric Infrastructure from the BSE500 index hit their respective new highs in an otherwise subdued market.
With significant untapped market opportunities and a shortage of healthcare infrastructure in India, leading Indian companies have immense potential for expansion.